MedPath
TGA Approval

ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and needle free diluent syringe (130161)

130161

ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and needle free diluent syringe

Sanofi-Aventis Australia Pty Ltd

December 6, 2006

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/f800c58ac80ef4b710773cb3705dfef0.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1e7be92a7358d2dd67461a07da31acff.pdf

Active Ingredients

Tetanus protein

Haemophilus type B polysaccharide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ACT-HIB haemophilus type B conjugate vaccine (conjugated to tetanus protein) powder for injection vial and needle free diluent syringe (130161) - TGA 批准文号 | MedPath